Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of SIM0270 in Healthy Adults
NCT06536036Phase 1Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Jul 2024
- Primary completion
- Oct 2024
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of SIM0270 in breast cancer (4 arms), sponsored by Simcere Pharmaceutical Group. Primary endpoints: Peak Plasma Concentration, Area Under the Curve and 1 more. Started Jul 2024; status: completed.
02
Drugs
SIM0270
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06536036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06536036.